Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature

Table 3 Treatment, coronary artery involvement, follow-up, and outcomes of patients who had pulmonary involvement associated with Kawasaki disease

Authors, year, reference number	Infectious agent	Antibiotic treatment	CAI	Treatment	Follow-up and outcome
Singh et al., 2018, [6]	2 ^a	11 ^a	3 ^a	2 ^a, Second dose of IVIG	9 ^a Normal, 2 ^a NA
Alhammadi and Hendaus, 2013, [12]	No	Yes	Yes	IVIG	Normal
Lee et al., 2011, [11]	NA	NA	NA	NA	NA
Lee et al., 2010, [14]	No	No	Yes	Second dose of IVIG and corticosteroid	Normal
Falcini et al., 2009, [15]	No	Yes	Yes	Second dose of IVIG and corticosteroid	Normal
Elizabeth et al., 2007, [16]	No	Yes	Yes	Second dose of IVIG and corticosteroid	Normal
Yavuz et al., 2007, [17]	No	Yes	Yes	Second dose of IVIG	Normal
Sittiwangkul and Pongprot, 2004, [13]	No	Yes	Yes	Second dose of IVIG and corticosteroid	Aneurysm persisted in 2 years
de Magalhães et al., 2012, [21]	No	Yes	Yes	Second dose of IVIG, corticosteroid, MTX, and ETN	Aneurysm decrease but persisted
Hamada et al., 2005, [18]	No	Yes	No	Second dose of IVIG and corticosteroid	Normal
D'Souza et al., 2006, [20]	No	Yes	No	IVIG	Normal
de Maddi et al., 2009, [22]
Case 1	No	Yes	No	IVIG	Normal
Case 2	No	Yes	No	Not given IVIG	Normal
Case 3	No	Yes	No	IVIG	Normal
Freeman et al., 2003, [23]
Case 1	No	Yes	Yes	IVIG	Death
Case 2	NA	Yes	Yes	IVIG	Normal
Case 3	No	Yes	Yes	IVIG	Normal
Kobayashi et al., 2006, [24]
Case 1	Yes	Yes	NA	IVIG	Normal
Case 2	Yes	Yes	NA	IVIG	Normal
Vaidya et al., 2017, [8]	No	Yes	Yes	IVIG	NA
Akagi et al., 2017, [19]
Case 1	No	No	Yes	IVIG	Normal
Case 2	No	Yes	Yes	IVIG	Normal

^aNumber of the patients
CAI coronary artery involvement, ETN etanercept, IVIG intravenous immunoglobulin, MTX methotrexate, NA not available

ISSN: 1752-1947